Tuesday, November 26, 2024

Popular diabetes and obesity drugs also protect kidneys, study shows

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.

from Top Health News -- ScienceDaily https://ift.tt/Wk0lJXR
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists reverse liver cell aging and cut Alzheimer’s-linked protein in half

A surprising discovery suggests that rejuvenating the liver could help protect against Alzheimer’s disease and heart disease. USC researcher...